This program is composed of 300 prescription drug diversion investigators and regulatory agencies who are surveyed quarterly and asked to report the number of new diversion cases investigated in that quarter.
Data is obtained from municipal police departments, multi-jurisdictional drug task forces, county sheriffs’ departments and other pharmaceutical boards and departments of health.
- Hilary L. Surratt, Ph.D. (Co-Principal Investigator)
- Steve Kurtz, Ph.D. (Co-Principal Investigator)
- Yamilka Stivers, B.A. (Project Director)
Center for Applied Research on Substance Use & Health Disparities
Nova Southeastern University